Erting Tang
Overview
Explore the profile of Erting Tang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang J, Pan T, Lee J, Goldberg S, King S, Tang E, et al.
Cell Rep Med
. 2025 Jan;
6(1):101920.
PMID: 39809265
Metabolic reprogramming of tumor cells is an emerging hallmark of cancer. Among all the changes in cancer metabolism, increased glucose uptake and the accumulation of lactate under normoxic conditions (the...
2.
Pan T, Cao G, Tang E, Zhao Y, Penaloza-MacMaster P, Fang Y, et al.
Front Genet
. 2023 Mar;
14:1105673.
PMID: 36992700
Within the inflammatory immune response to viral infection, the distribution and cell type-specific profiles of immune cell populations and the immune-mediated viral clearance pathways vary according to the specific virus....
3.
Ye L, Park J, Peng L, Yang Q, Chow R, Dong M, et al.
Cell Metab
. 2022 Mar;
34(4):595-614.e14.
PMID: 35276062
Chimeric antigen receptor (CAR)-T cell-based immunotherapy for cancer and immunological diseases has made great strides, but it still faces multiple hurdles. Finding the right molecular targets to engineer T cells...
4.
Pan T, Cao G, Tang E, Zhao Y, Penaloza-MacMaster P, Fang Y, et al.
bioRxiv
. 2022 Jan;
PMID: 35043114
Highlights: COVID-19 and HIV-1 patients show disease-specific inflammatory immune signatures COVID-19 patients show more productive humoral responses than HIV-1 patients SARS-CoV-2 elicits more enriched IFN-I signaling relative to HIV-IDivergent, impaired...